Department of Neuroscience, Imperial College London, South Kensington, London, SW7 2AZ, UK.
Institute of Cardiovascular Research Royal Holloway, University of London, Egham, Surrey, TW20 0EX, UK.
Neurol Sci. 2019 Dec;40(12):2437-2445. doi: 10.1007/s10072-019-04024-w. Epub 2019 Jul 29.
The influences of genetic variants on functional clinical outcomes following stroke are unclear. In order to reliably quantify these influences, we undertook a comprehensive meta-analysis of outcomes after acute intracerebral haemorrhage (ICH) or ischaemic stroke (AIS) in relation to different genetic variants.
PubMed, PsycInfo, Embase and Medline electronic databases were searched up to January 2019. Outcomes, defined as favourable or poor, were assessed by validated scales (Barthel index, modified Rankin scale, Glasgow outcome scale and National Institutes of Health stroke scale).
Ninety-two publications comprising 31,895 cases met our inclusion criteria. Poor outcome was observed in patients with ICH who possessed the APOE4 allele: OR =2.60 (95% CI = 1.25-5.41, p = 0.01) and in AIS patients with the GA or AA variant at the BDNF-196 locus: OR = 2.60 (95% CI = 1.25-5.41, p = 0.01) or a loss of function allele of CYP2C19: OR = 2.36 (95% CI = 1.56-3.55, p < 0.0001). Poor outcome was not associated with APOE4: OR = 1.02 (95% CI = 0.81-1.27, p = 0.90) or IL6-174 G/C: OR = 2.21 (95% CI = 0.55-8.86, p = 0.26) in patients with AIS.
We demonstrate that recovery of AIS was unfavourably associated with variants of BDNF and CYP2C19 genes whilst recovery of ICH was unfavourably associated with APOE4 gene.
遗传变异对中风后功能临床结局的影响尚不清楚。为了可靠地量化这些影响,我们对急性脑出血(ICH)或缺血性中风(AIS)后与不同遗传变异相关的结果进行了全面的荟萃分析。
检索了 PubMed、PsycInfo、Embase 和 Medline 电子数据库,截至 2019 年 1 月。通过经过验证的量表(巴氏指数、改良 Rankin 量表、格拉斯哥结局量表和国立卫生研究院中风量表)评估有利或不良结局。
92 篇文献共纳入 31895 例患者符合纳入标准。携带 APOE4 等位基因的 ICH 患者预后不良:OR=2.60(95%CI=1.25-5.41,p=0.01),BDNF-196 基因位点 GA 或 AA 变异的 AIS 患者预后不良:OR=2.60(95%CI=1.25-5.41,p=0.01)或 CYP2C19 功能丧失等位基因:OR=2.36(95%CI=1.56-3.55,p<0.0001)。APOE4:OR=1.02(95%CI=0.81-1.27,p=0.90)或 AIS 患者 IL6-174 G/C:OR=2.21(95%CI=0.55-8.86,p=0.26)与不良预后无关。
我们证明 AIS 的恢复与 BDNF 和 CYP2C19 基因的变异不利相关,而 ICH 的恢复与 APOE4 基因不利相关。